about
Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer.Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.Prognostic significance of CT-emphysema score in patients with advanced squamous cell lung cancer.Second-line therapy of squamous non-small cell lung cancer: an evolving landscape.Histologic subtypes are not associated with the presence of sarcopenia in lung cancer.
P2860
Q37210782-285070F0-27F0-4707-8430-D9AD5C6A480AQ37598057-68584A98-3849-4BB4-A89C-D543D2792F71Q38824891-CDE9CA9E-CF44-4AD1-A09B-0C5250ED95E6Q40610329-41607E56-D997-4229-8F05-3F4E012A4A3AQ41115024-1DB44802-0577-44B5-B6E5-FF4ABFC4CCB5Q47861831-4EA47AAF-AA7B-4B8B-98A3-DA302F4C3C2CQ52723567-E9A74079-2C3F-4165-BB32-FDBEE9AA7BD9
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging drugs for squamous cell lung cancer.
@en
type
label
Emerging drugs for squamous cell lung cancer.
@en
prefLabel
Emerging drugs for squamous cell lung cancer.
@en
P2093
P2860
P1476
Emerging drugs for squamous cell lung cancer.
@en
P2093
Haiying Cheng
Huijie Liu
Karthikeya Kandavelou
Marina Shcherba
Roman Perez-Soler
Yuanxin Liang
P2860
P304
P356
10.1517/14728214.2015.1001365
P407
P577
2015-01-05T00:00:00Z